H. Sung, J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer J. Clin. 71, 209–249 (2021)
R.S. Herbst, D. Morgensztern, C. Boshoff, The biology and management of non-small cell lung cancer. Nature 553, 446–454 (2018)
M. Elbadawy, T. Usui, T. Mori, R. Tsunedomi, S. Hazama, R. Nabeta, T. Uchide, R. Fukushima, T. Yoshida, M. Shibutani, T. Tanaka, S. Masuda, R. Okada, R. Ichikawa, T. Omatsu, T. Mizutani, Y. Katayama, S. Noguchi, S. Iwai, T. Nakagawa, Y. Shinohara, M. Kaneda, H. Yamawaki, K. Sasaki, Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture. Cancer Sci. 110, 2806–2821 (2019)
S.Y. Kim, S.M. Kim, S. Lim, J.Y. Lee, S.J. Choi, S.D. Yang, M.R. Yun, C.G. Kim, S.R. Gu, C. Park, A.Y. Park, S.M. Lim, S.G. Heo, H. Kim, B. C. Cho, Modeling clinical responses to targeted therapies by patient-derived organoids of advanced lung adenocarcinoma. Clin. Cancer Res. 27, 4397–4409 (2021)
Z. Li, Y. Qian, W. Li, L. Liu, L. Yu, X. Liu, G. Wu, Y. Wang, W. Luo, F. Fang, Y. Liu, F. Song, Z. Cai, W. Chen, W. Huang, Human lung adenocarcinoma-derived organoid models for drug screening. iScience23, 101411 (2020)
D. Tuveson, H. Clevers, Cancer modeling meets human organoid technology. Science 364, 952–955 (2019)
M. Elbadawy, Y. Sato, T. Mori, Y. Goto, K. Hayashi, M. Yamanaka, D. Azakami, T. Uchide, R. Fukushima, T. Yoshida, M. Shibutani, M. Kobayashi, Y. Shinohara, A. Abugomaa, M. Kaneda, H. Yamawaki, T. Usui, K. Sasaki, Anti-tumor effect of trametinib in bladder cancer organoid and the underlying mechanism. Cancer Biol. Ther. 22, 357–371 (2021)
F. Chen, J. Liu, R.M. Flight, K.J. Naughton, A. Lukyanchuk, A.R. Edgin, X. Song, H. Zhang, K.K. Wong, H.N.B. Moseley, C. Wang, C.F. Brainson, Cellular origins of EGFR-driven lung cancer cells determine sensitivity to therapy. Adv. Sci. 8, e2101999 (2021)
Y. Hu, X. Sui, F. Song, Y. Li, K. Li, Z. Chen, F. Yang, X. Chen, Y. Zhang, X. Wang, Q. Liu, C. Li, B. Zou, X. Chen, J. Wang, P. Liu, Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week. Nat. Commun. 12, 2581 (2021)
N. Takahashi, H. Hoshi, A. Higa, G. Hiyama, H. Tamura, M. Ogawa, K. Takagi, K. Goda, N. Okabe, S. Muto, H. Suzuki, K. Shimomura, S. Watanabe, M. Takagi, An in vitro system for evaluating molecular targeted drugs using lung patient-derived tumor organoids. Cells 8, 481 (2019)
K.K. Dijkstra, K. Monkhorst, L.J. Schipper, K.J. Hartemink, E.F. Smit, S. Kaing, R. de Groot, M.C. Wolkers, H. Clevers, E. Cuppen, E. E. Voest, Challenges in establishing pure lung cancer organoids limit their utility for personalized medicine. Cell Rep. 31, 107588 (2020)
C.M. Della Corte, G. Barra, V. Ciaramella, R. Di Liello, G. Vicidomini, S. Zappavigna, A. Luce, M. Abate, A. Fiorelli, M. Caraglia, M. Santini, E. Martinelli, T. Troiani, F. Ciardiello, F. Morgillo, Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures. J. Exp. Clin. Cancer Res. 38, 253 (2019)
K.K. Dijkstra, C.M. Cattaneo, F. Weeber, M. Chalabi, J. van de Haar, L.F. Fanchi, M. Slagter, D.L. van der Velden, S. Kaing, S. Kelderman, N. van Rooij, M.E. van Leerdam, A. Depla, E.F. Smit, K.J. Hartemink, R. de Groot, M.C. Wolkers, N. Sachs, P. Snaebjornsson, K. Monkhorst, J. Haanen, H. Clevers, T.N. Schumacher, E. E. Voest, Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids. Cell 174, 1586–1598 e1512 (2018)
C. Zheng, Y.H. Sun, X.L. Ye, H.Q. Chen, H.B. Ji, Establishment and characterization of primary lung cancer cell lines from chinese population. Acta Pharmacol. Sin 32, 385–392 (2011)
A.F. Gazdar, B. Gao, J.D. Minna, Lung cancer cell lines: useless artifacts or invaluable tools for medical science? Lung Cancer 68, 309–318 (2010)
D.W. Hutmacher, Biomaterials offer cancer research the third dimension. Nat. Mater. 9, 90–93 (2010)
U. Ben-David, B. Siranosian, G. Ha, H. Tang, Y. Oren, K. Hinohara, C.A. Strathdee, J. Dempster, N.J. Lyons, R. Burns, A. Nag, G. Kugener, B. Cimini, P. Tsvetkov, Y.E. Maruvka, R. O’Rourke, A. Garrity, A.A. Tubelli, P. Bandopadhayay, A. Tsherniak, F. Vazquez, B. Wong, C. Birger, M. Ghandi, A.R. Thorner, J.A. Bittker, M. Meyerson, G. Getz, R. Beroukhim, T.R. Golub, Genetic and transcriptional evolution alters cancer cell line drug response. Nature 560, 325–330 (2018)
J.L. Wilding, W.F. Bodmer, Cancer cell lines for drug discovery and development. Cancer Res. 74, 2377–2384 (2014)
G.J. Yoshida, Applications of patient-derived tumor xenograft models and tumor organoids. J. Hematol. Oncol. 13, 4 (2020)
I.M. Meraz, M. Majidi, F. Meng, R. Shao, M.J. Ha, S. Neri, B. Fang, S.H. Lin, P.T. Tinkey, E.J. Shpall, J. Morris, J.A. Roth, An improved patient-derived xenograft humanized mouse model for evaluation of lung cancer immune responses. Cancer Immunol. Res. 7, 1267–1279 (2019)
S. Abdolahi, Z. Ghazvinian, S. Muhammadnejad, M. Saleh, H. Asadzadeh Aghdaei, K. Baghaei, Patient-derived xenograft (PDX) models, applications and challenges in cancer research. J. Transl Med. 20, 206 (2022)
M.R. Junttila, F.J. de Sauvage, Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501, 346–354 (2013)
R. Shi, N. Radulovich, C. Ng, N. Liu, H. Notsuda, M. Cabanero, S.N. Martins-Filho, V. Raghavan, Q. Li, A.S. Mer, J.C. Rosen, M. Li, Y.H. Wang, L. Tamblyn, N.A. Pham, B. Haibe-Kains, G. Liu, N. Moghal, M.S. Tsao, Organoid cultures as preclinical models of Non-Small Cell Lung Cancer. Clin. Cancer Res. 26, 1162–1174 (2020)
A. Miura, D. Yamada, M. Nakamura, S. Tomida, D. Shimizu, Y. Jiang, T. Takao, H. Yamamoto, K. Suzawa, K. Shien, M. Yamane, M. Sakaguchi, S. Toyooka, T. Takarada, Oncogenic potential of human pluripotent stem cell-derived lung organoids with HER2 overexpression. Int. J. Cancer 149, 1593–1604 (2021)
S.Y. Choi, Y.H. Cho, D.S. Kim, W. Ji, C.M. Choi, J.C. Lee, J.K. Rho, G.S. Jeong, Establishment and long-term expansion of small cell Lung Cancer patient-derived Tumor Organoids. Int. J. Mol. Sci. 22, 1349 (2021)
J.H. Chen, X.P. Chu, J.T. Zhang, Q. Nie, W.F. Tang, J. Su, H.H. Yan, H.P. Zheng, Z.X. Chen, X. Chen, M.M. Song, X. Yi, P.S. Li, Y.F. Guan, G. Li, C.X. Deng, R. Rosell, Y.L. Wu, W. Z. Zhong, genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients. Thorac. Cancer 11, 2279–2290 (2020)
M. Kim, H. Mun, C.O. Sung, E.J. Cho, H.J. Jeon, S.M. Chun, D.J. Jung, T.H. Shin, G.S. Jeong, D.K. Kim, E.K. Choi, S.Y. Jeong, A.M. Taylor, S. Jain, M. Meyerson, S.J. Jang, Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening. Nat. Commun. 10, 3991 (2019)
P.H. Chen, L. Cai, K. Huffman, C. Yang, J. Kim, B. Faubert, L. Boroughs, B. Ko, J. Sudderth, E.A. McMillan, L. Girard, D. Chen, M. Peyton, M.D. Shields, B. Yao, D.S. Shames, H.S. Kim, B. Timmons, I. Sekine, R. Britt, S. Weber, L.A. Byers, J.V. Heymach, J. Chen, M.A. White, J.D. Minna, G. Xiao, R.J. DeBerardinis, Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells. Mol. Cell 76, 838–851 e835 (2019)
A.G. Cox, K.L. Hwang, K.K. Brown, K. Evason, S. Beltz, A. Tsomides, K. O’Connor, G.G. Galli, D. Yimlamai, S. Chhangawala, M. Yuan, E.C. Lien, J. Wucherpfennig, S. Nissim, A. Minami, D.E. Cohen, F.D. Camargo, J.M. Asara, Y. Houvras, D.Y.R. Stainier, W. Goessling, Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth. Nat. Cell. Biol. 18, 886–896 (2016)
J.S. Zhao, S. Shi, H.Y. Qu, Z. Keckesova, Z.J. Cao, L.X. Yang, X. Yu, L. Feng, Z. Shi, J. Krakowiak, R.Y. Mao, Y.T. Shen, Y.M. Fan, T.M. Fu, C. Ye, D. Xu, X. Gao, J. You, W. Li, T. Liang, Z. Lu, Y.X. Feng, Glutamine synthetase licenses APC/C-mediated mitotic progression to drive cell growth. Nat. Metab. 4, 239–253 (2022)
B. Chen, Y. Song, Y. Zhan, S. Zhou, J. Ke, W. Ao, Y. Zhang, Q. Liang, M. He, S. Li, F. Xie, H. Huang, W.N. Chan, A.H.K. Cheung, B.B.Y. Ma, W. Kang, K.F. To, J. Xiao, Fangchinoline inhibits non-small cell lung cancer metastasis by reversing epithelial-mesenchymal transition and suppressing the cytosolic ROS-related Akt-mTOR signaling pathway. Cancer Lett. 543, 215783 (2022)
B.A. Windmoller, M. Beshay, L.P. Helweg, C. Flottmann, M. Beermann, C. Forster, L. Wilkens, J.F.W. Greiner, C. Kaltschmidt, B. Kaltschmidt, Novel primary human cancer stem-like cell populations from non-small cell lung cancer: inhibition of cell survival by targeting NF-kappaB and MYC signaling. Cells 10, 1024 (2021)
J.A. Taverna, C.N. Hung, D.T. DeArmond, M. Chen, C.L. Lin, P.A. Osmulski, M.E. Gaczynska, C.M. Wang, N.D. Lucio, C.W. Chou, C.L. Chen, A. Nazarullah, S.R. Lampkin, L. Qiu, D.J. Bearss, S. Warner, C.J. Whatcott, L. Mouritsen, M. Wade, S. Weitman, R.A. Mesa, N.B. Kirma, W.T. Chao, T. H. Huang, Single-cell proteomic profiling identifies combined AXL and JAK1 inhibition as a novel therapeutic strategy for lung cancer. Cancer Res. 80, 1551–1563 (2020)
S.P. Rowbotham, F. Li, A.F.M. Dost, S.M. Louie, B.P. Marsh, P. Pessina, C.R. Anbarasu, C.F. Brainson, S.J. Tuminello, A. Lieberman, S. Ryeom, T.M. Schlaeger, B.J. Aronow, H. Watanabe, K.K. Wong, C.F. Kim, H3K9 methyltransferases and demethylases control lung tumor-propagating cells and lung cancer progression. Nat. Commun. 9, 4559 (2018)
L.J. Marshall, M. Triunfol, T. Seidle, Patient-derived xenograft vs. organoids: a preliminary analysis of cancer research output, funding and human health impact in 2014–2019. Animals 10, 1923 (2020)
N. Sachs, A. Papaspyropoulos, D.D. Zomer-van Ommen, I. Heo, L. Bottinger, D. Klay, F. Weeber, G. Huelsz-Prince, N. Iakobachvili, G.D. Amatngalim, J. de Ligt, A. van Hoeck, N. Proost, M.C. Viveen, A. Lyubimova, L. Teeven, S. Derakhshan, J. Korving, H. Begthel, J.F. Dekkers, K. Kumawat, E. Ramos, M.F. van Oosterhout, G.J. Offerhaus, D.J. Wiener, E.P. Olimpio, K.K. Dijkstra, E.F. Smit, M. van der Linden, S. Jaksani, M. van de Ven, J. Jonkers, A.C. Rios, E.E. Voest, C.H. van Moorsel, C.K. van der Ent, E. Cuppen, A. van Oudenaarden, F.E. Coenjaerts, L. Meyaard, L.J. Bont, P.J. Peters, S.J. Tans, J.S. van Zon, S.F. Boj, R.G. Vries, J.M. Beekman, H. Clevers, Long-term expanding human airway organoids for disease modeling. Embo J. 38, e100300 (2019)
Y. Wang, T. Jiang, Z. Qin, J. Jiang, Q. Wang, S. Yang, C. Rivard, G. Gao, T.L. Ng, M.M. Tu, H. Yu, H. Ji, C. Zhou, S. Ren, J. Zhang, P. Bunn, R.C. Doebele, D.R. Camidge, F.R. Hirsch, HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib. Ann. Oncol. 30, 447–455 (2019)
Z. Zeng, J. Li, J. Zhang, Y. Li, X. Liu, J. Chen, Z. Huang, Q. Wu, Y. Gong, C. Xie, Immune and stromal scoring system associated with tumor microenvironment and prognosis: a gene-based multi-cancer analysis. J. Transl Med. 19, 330 (2021)
D. Lambrechts, E. Wauters, B. Boeckx, S. Aibar, D. Nittner, O. Burton, A. Bassez, H. Decaluwe, A. Pircher, K. Van den Eynde, B. Weynand, E. Verbeken, P. De Leyn, A. Liston, J. Vansteenkiste, P. Carmeliet, S. Aerts, B. Thienpont, Phenotype molding of stromal cells in the lung tumor microenvironment. Nat. Med. 24, 1277–1289 (2018)
D.F. Quail, J.A. Joyce, Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423–1437 (2013)
留言 (0)